REIT - Mortgage
Compare Stocks
4 / 10Stock Comparison
MFAN vs WELL vs VTR vs MFA
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Mortgage
MFAN vs WELL vs VTR vs MFA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | REIT - Mortgage | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Mortgage |
| Market Cap | $2.57B | $149.25B | $41.15B | $995M |
| Revenue (TTM) | $418M | $11.63B | $6.13B | $650M |
| Net Income (TTM) | $177M | $1.43B | $260M | $135M |
| Gross Margin | 116.7% | 39.1% | -4.3% | 59.3% |
| Operating Margin | 63.3% | 4.4% | 13.4% | 41.0% |
| Forward P/E | 18.4x | 78.4x | 118.0x | 7.1x |
| Total Debt | $10.99B | $21.38B | $13.22B | $10.99B |
| Cash & Equiv. | $213M | $5.03B | $741M | $213M |
MFAN vs WELL vs VTR vs MFA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 24 | May 26 | Return |
|---|---|---|---|
| MFA Financial, Inc.… (MFAN) | 100 | 100.6 | +0.6% |
| Welltower Inc. (WELL) | 100 | 246.2 | +146.2% |
| Ventas, Inc. (VTR) | 100 | 186.5 | +86.5% |
| MFA Financial, Inc. (MFA) | 100 | 88.1 | -11.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MFAN vs WELL vs VTR vs MFA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MFAN has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.54, yield 7.1%
- Rev growth 213.0%, EPS growth 104.9%
- 213.0% FFO/revenue growth vs VTR's 18.5%
- 42.2% margin vs VTR's 4.2%
WELL is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 223.1% 10Y total return vs VTR's 65.0%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- Beta 0.13, yield 1.3%, current ratio 5.34x
- +42.7% vs MFAN's +10.3%
VTR is the clearest fit if your priority is stability.
- Beta 0.01 vs MFA's 0.77, lower leverage
MFA is the clearest fit if your priority is value and dividends.
- Lower P/E (7.1x vs 118.0x)
- 18.4% yield, 1-year raise streak, vs WELL's 1.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 213.0% FFO/revenue growth vs VTR's 18.5% | |
| Value | Lower P/E (7.1x vs 118.0x) | |
| Quality / Margins | 42.2% margin vs VTR's 4.2% | |
| Stability / Safety | Beta 0.01 vs MFA's 0.77, lower leverage | |
| Dividends | 18.4% yield, 1-year raise streak, vs WELL's 1.3% | |
| Momentum (1Y) | +42.7% vs MFAN's +10.3% | |
| Efficiency (ROA) | 2.3% ROA vs VTR's 1.0%, ROIC 0.5% vs 2.5% |
MFAN vs WELL vs VTR vs MFA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
MFAN vs WELL vs VTR vs MFA — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MFAN leads in 2 of 6 categories
MFA leads 1 • WELL leads 1 • VTR leads 1 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MFAN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 27.8x MFAN's $418M. MFAN is the more profitable business, keeping 42.2% of every revenue dollar as net income compared to VTR's 4.2%. On growth, MFA holds the edge at +118.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $418M | $11.6B | $6.1B | $650M |
| EBITDAEarnings before interest/tax | $266M | $2.8B | $2.3B | $268M |
| Net IncomeAfter-tax profit | $177M | $1.4B | $260M | $135M |
| Free Cash FlowCash after capex | $76M | $2.5B | $1.4B | $91M |
| Gross MarginGross profit ÷ Revenue | +116.7% | +39.1% | -4.3% | +59.3% |
| Operating MarginEBIT ÷ Revenue | +63.3% | +4.4% | +13.4% | +41.0% |
| Net MarginNet income ÷ Revenue | +42.2% | +12.3% | +4.2% | +20.7% |
| FCF MarginFCF ÷ Revenue | +18.2% | +21.9% | +22.4% | +14.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +111.3% | +40.3% | +22.0% | +118.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +27.0% | +22.5% | 0.0% | -103.0% |
Valuation Metrics
MFA leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 5.8x trailing earnings, MFA trades at a 96% valuation discount to VTR's 160.3x P/E. On an enterprise value basis, MFA's 17.1x EV/EBITDA is more attractive than WELL's 66.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $2.6B | $149.2B | $41.1B | $995M |
| Enterprise ValueMkt cap + debt − cash | $13.3B | $165.6B | $53.6B | $11.8B |
| Trailing P/EPrice ÷ TTM EPS | 14.97x | 153.25x | 160.26x | 5.80x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.45x | 78.42x | 118.01x | 7.11x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 19.34x | 66.40x | 24.31x | 17.07x |
| Price / SalesMarket cap ÷ Revenue | 2.93x | 13.99x | 7.05x | 1.14x |
| Price / BookPrice ÷ Book value/share | 1.45x | 3.35x | 3.18x | 0.56x |
| Price / FCFMarket cap ÷ FCF | 33.68x | 52.41x | 31.25x | 13.06x |
Profitability & Efficiency
MFAN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MFAN delivers a 9.7% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $2 for VTR. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to MFA's 6.01x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs MFA's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.7% | +3.5% | +2.1% | +7.4% |
| ROA (TTM)Return on assets | +1.5% | +2.3% | +1.0% | +1.1% |
| ROICReturn on invested capital | +4.4% | +0.5% | +2.5% | +4.4% |
| ROCEReturn on capital employed | +5.8% | +0.6% | +3.2% | +5.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 5 |
| Debt / EquityFinancial leverage | 6.01x | 0.49x | 1.05x | 6.01x |
| Net DebtTotal debt minus cash | $10.8B | $16.3B | $12.5B | $10.8B |
| Cash & Equiv.Liquid assets | $213M | $5.0B | $741M | $213M |
| Total DebtShort + long-term debt | $11.0B | $21.4B | $13.2B | $11.0B |
| Interest CoverageEBIT ÷ Interest expense | 1.34x | 0.26x | 1.40x | 1.34x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $9,942 for MFA. Over the past 12 months, WELL leads with a +42.7% total return vs MFAN's +10.3%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs MFAN's 6.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.8% | +14.3% | +12.6% | +6.1% |
| 1-Year ReturnPast 12 months | +10.3% | +42.7% | +33.9% | +19.2% |
| 3-Year ReturnCumulative with dividends | +20.2% | +189.5% | +94.2% | +34.1% |
| 5-Year ReturnCumulative with dividends | +20.2% | +202.3% | +74.8% | -0.6% |
| 10-Year ReturnCumulative with dividends | +20.2% | +223.1% | +65.0% | +7.8% |
| CAGR (3Y)Annualised 3-year return | +6.3% | +42.5% | +24.8% | +10.3% |
Risk & Volatility
VTR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
VTR is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than MFA's 0.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs MFA's 92.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.54x | 0.13x | 0.01x | 0.77x |
| 52-Week HighHighest price in past year | $26.50 | $219.59 | $88.50 | $10.57 |
| 52-Week LowLowest price in past year | $8.60 | $142.65 | $61.76 | $8.78 |
| % of 52W HighCurrent price vs 52-week peak | +94.9% | +97.0% | +97.8% | +92.2% |
| RSI (14)Momentum oscillator 0–100 | 51.8 | 60.2 | 56.2 | 43.8 |
| Avg Volume (50D)Average daily shares traded | 20K | 2.6M | 3.4M | 1.4M |
Analyst Outlook
Evenly matched — WELL and MFA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WELL as "Buy", VTR as "Buy", MFA as "Hold". Consensus price targets imply 6.3% upside for WELL (target: $227) vs 4.9% for VTR (target: $91). For income investors, MFA offers the higher dividend yield at 18.36% vs WELL's 1.30%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $226.50 | $90.80 | $10.25 |
| # AnalystsCovering analysts | — | 34 | 32 | 22 |
| Dividend YieldAnnual dividend ÷ price | +7.1% | +1.3% | +2.1% | +18.4% |
| Dividend StreakConsecutive years of raises | 1 | 2 | 1 | 1 |
| Dividend / ShareAnnual DPS | $1.79 | $2.76 | $1.86 | $1.79 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | 0.0% | 0.0% | +1.5% |
MFAN leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MFA leads in 1 (Valuation Metrics). 1 tied.
MFAN vs WELL vs VTR vs MFA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MFAN or WELL or VTR or MFA a better buy right now?
For growth investors, MFA Financial, Inc.
8. 875% Senior Notes (MFAN) is the stronger pick with 213. 0% revenue growth year-over-year, versus 18. 5% for Ventas, Inc. (VTR). MFA Financial, Inc. (MFA) offers the better valuation at 5. 8x trailing P/E (7. 1x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MFAN or WELL or VTR or MFA?
On trailing P/E, MFA Financial, Inc.
(MFA) is the cheapest at 5. 8x versus Ventas, Inc. at 160. 3x. On forward P/E, MFA Financial, Inc. is actually cheaper at 7. 1x.
03Which is the better long-term investment — MFAN or WELL or VTR or MFA?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -0. 6% for MFA Financial, Inc. (MFA). Over 10 years, the gap is even starker: WELL returned +223. 1% versus MFA's +7. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MFAN or WELL or VTR or MFA?
By beta (market sensitivity over 5 years), Ventas, Inc.
(VTR) is the lower-risk stock at 0. 01β versus MFA Financial, Inc. 's 0. 77β — meaning MFA is approximately 8033% more volatile than VTR relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 6% for MFA Financial, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MFAN or WELL or VTR or MFA?
By revenue growth (latest reported year), MFA Financial, Inc.
8. 875% Senior Notes (MFAN) is pulling ahead at 213. 0% versus 18. 5% for Ventas, Inc. (VTR). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MFAN or WELL or VTR or MFA?
MFA Financial, Inc.
8. 875% Senior Notes (MFAN) is the more profitable company, earning 20. 2% net margin versus 4. 3% for Ventas, Inc. — meaning it keeps 20. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MFAN leads at 78. 8% versus 3. 3% for WELL. At the gross margin level — before operating expenses — MFAN leads at 96. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MFAN or WELL or VTR or MFA more undervalued right now?
On forward earnings alone, MFA Financial, Inc.
(MFA) trades at 7. 1x forward P/E versus 118. 0x for Ventas, Inc. — 110. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WELL: 6. 3% to $226. 50.
08Which pays a better dividend — MFAN or WELL or VTR or MFA?
All stocks in this comparison pay dividends.
MFA Financial, Inc. (MFA) offers the highest yield at 18. 4%, versus 1. 3% for Welltower Inc. (WELL).
09Is MFAN or WELL or VTR or MFA better for a retirement portfolio?
For long-horizon retirement investors, Ventas, Inc.
(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Both have compounded well over 10 years (VTR: +65. 0%, MFA: +7. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MFAN and WELL and VTR and MFA?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.